11 Citations (Scopus)
176 Downloads (Pure)

Abstract

Giant cell arteritis is the principal form of systemic vasculitis affecting people over 50. Large-vessel involvement, termed large vessel giant cell arteritis, mainly affects the aorta and its branches, often occurring alongside cranial giant cell arteritis, but large vessel giant cell arteritis without cranial giant cell arteritis can also occur. Patients mostly present with constitutional symptoms, with localising large vessel giant cell arteritis symptoms present in a minority of patients only. Large vessel giant cell arteritis is usually overlooked until clinicians seek to exclude it with imaging by ultrasonography, magnetic resonance angiography (MRA), computed tomography angiography (CTA), or [ 18F]fluorodeoxyglucose-PET-CT. Although the role of imaging in treatment monitoring remains uncertain, imaging by MRA or CTA is crucial for identifying aortic aneurysm formation during patient follow up. In this Series paper, we define the large vessel subset of giant cell arteritis and summarise its clinical challenges. Furthermore, we identify areas for future research regarding the management of large vessel giant cell arteritis.

Original languageEnglish
Pages (from-to)e397-e408
Number of pages12
JournalThe Lancet Rheumatology
Volume6
Issue number6
Early online date1-Apr-2024
DOIs
Publication statusPublished - Jun-2024

Fingerprint

Dive into the research topics of 'Large vessel giant cell arteritis'. Together they form a unique fingerprint.

Cite this